All analyses were conducted using the SPSS Statistics 19.0 software (IBM, USA)
Petersen, K
Brito A, Verdugo R, Hertrampf E, Miller JW, Green R, Fedosov SN, Shahab-Ferdows S, Sanchez H, Albala C, Castillo JL et al
N Engl J Med 350(23):23352342 Kabbinavar FF et al (2005) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
GLP-1 is particularly relevant in conditions such as type 2 diabetes and obesity, both of which are associated with impaired glucose regulation
The treatment also appeared to ameliorate cardiovascular risk, as endothelial function improved by the end of the treatment period